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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S149patients with mild to moderate knee OA, aged 18-65 years, receiving
usual care for more than 6 months were included. Patients were
randomized into a control group receiving usual care or into an inter-
vention group receiving usual care with 3 additional intra articular
injections with high MW HA. Data on pain during rest / activity, func-
tion and global assessment were collected during 12 months follow-up.
The primary outcome was deﬁned as response to therapy according to
OMERACT-OARSI criteria (improvement of at least 20% in at least 2 of
the 3 following domains: pain in rest / pain during activity, function and
patients global assessment) after 12 months of follow-up. Adverse
events were registered during follow-up.
Results: In total, 156 subjects were included of which 77 patients in the
intervention group and 79 subjects in the control group. There were
statistically signiﬁcant more responders in the intervention groupwhen
pain during rest was included in responder criteria (51.9% versus 26.7%,
p¼0.001) after 12 months. With pain during activity as responder
criteria, this difference was also statistically signiﬁcant favouring the
intervention group (51.9% versus 25.3%, p¼0.001). Also on the indi-
vidual outcomes of the responder criteria signiﬁcant differences were
found between both groups favouring the intervention group.
Conclusions: Intra articular HA added to usual care leads to signiﬁ-
cantly more responders according to OMERACT-OARSI criteria after 12
months.
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THE VISK STUDY: A COST UTILITY ANALYSIS OF INTRA ARTICULAR
HYALURONIC ACID FOR KNEE OSTEOARTHRITIS
J. Hermans y, M. Reijman y, H. Verburg z, S.M. Bierma-Zeinstra y,
M.A. Koopmanschap y. y Erasmus MC, Rotterdam, The Netherlands;
zReinier de Graaf Hosp., Delft, The Netherlands
Purpose: Intra articular hyaluronic acid (HA) is included in treatment
guidelines of the Dutch Orthopaedic Society for the treatment of knee
osteoarthritis (OA). However, it is not reimbursed by insurance
companies in The Netherlands due to the fact that cost-utility of intra
articular HA is unknown for the Dutch healthcare system. The primary
goal of this studywas to determine the cost-utility of intra articular high
molecular weight (MW) HA added to usual care compared to usual care
in patients with knee OA.
Methods: Cost utility and clinical effectiveness were investigated in this
randomized clinical trial. Consecutive knee OA patients with mild to
moderate knee OA, aged 18-65 year, receiving usual care for more than
6 months were included in 2 hospitals in The Netherlands. Patients
were randomized into a control group receiving usual care or into an
intervention group receiving usual care with additionally intra articular
high MW HA. Data on medical costs, productivity costs and quality of
life were collected through questionnaires during 12 months follow-up.
Results: In total, 156 subjects were included of which 77 patients in the
intervention group and 79 subjects in the control group. The mean
annual productivity costs were higher in the intervention group (V6.542
(SD V9.837) versus V5.425 (SD V7.118), p¼0.796). The mean total
medical costs were also higher in the intervention group (V1.656 (SD
V2.331) versus V1.112 (SD V2.084), p¼0.003). The total annual mean
costs were higher in the intervention group (V8.198 (SDV1.1382) versus
V6.537 (SD V7.915), p¼0.383). Patients in the intervention group
experienced ahigher and statistically signiﬁcant quality of life during the
course of the follow-upperiod (p¼<0.0001). The higher costs andhigher
quality of life in the intervention group resulted in a cost-effectiveness
ratio of V79.268 per quality adjusted life year (QALY) using the societal
perspective, and V25.948 per QALY using the healthcare perspective.
Conclusions: Adding Intra articular HA to usual care in knee OA is more
effective, but only moderately cost-effective, regarding current stan-
dards for reimbursement in the Netherlands.
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PARQVE – PROJECT ARTHRITIS RECOVERING QUALITY OF LIFE BY
MEANS OF EDUCATION – A PILOT STUDY IN BRAZIL
M.U. Rezende, G.C. Campos, A.F. Pailo, R. Frucchi, T. Pasqualin,
M.I. Hissadomi, N.L. Brito, F.E. Farias, A.P. Monteiro, C.A. Silva,
C.H. Cernigoy. Faculdade Med. USP, Sao Paulo, Brazil
Purpose: The primary objective was to evaluate the improvement of
pain and function of patients with knee OA exposed to a multidisci-
plinary education program. Secondary Objectives were to evaluate
patients’ weight loss and increase in physical activity.Methods: Two hundred and twenty-two patients (54 men and 168
women) with knee OAwere randomly divided into four groups. Patients
underwent pre-assessment and two days of workshops with a multidis-
ciplinary team composed of psychologists; nutritionist; social workers;
physiotherapists; occupational therapists and orthopedic surgeons.
Patients answered evaluation questionnaires (VAS,WOMAC, LEQUESNE)
at inclusion and one year after classes. Three groups participated in two
workshopswith varying time interval between eachworkshop (Group 1,
3months apart; Group 2, 2 months apart; Group 3, 1 month apart. Group
4, control, only received handouts and video as all patients. Patients
responded how many times a week they exercised during the year.To
compare the means between the groups in the assessments of VAS,
WOMAC, Lequesne and BMI, ANOVA was used with repeated measures.
To compare the average weekly exercises between groups ANOVA was
used. The Tukey test was used for multiple comparisons when signiﬁ-
cance was found. The data were processed in SPSS V. 18.0 and the
signiﬁcance level used for the tests was a ¼ 0.05. Data are presented as
mean (standard deviation) at baseline and after 1 year.
Results: Baseline VAS was 53.33 (27.45) in Group 1, 64.58 (25.96) in
Group 2; 57.81 (24.91); Group 3; and 55.70 (26.71) in Group 4. At one
year the average VAS was according to groups: 1: 55.81(22.90); 2:
52.42(25.93); 3: 52.87(21.78); 4: 57.27(24.72). There was a differ-
ence between groups after one year (p¼0.03) but the Tukey test was not
able to verify which group was different. Baseline WOMAC was
1:43.37(19.15); 2: 46.69(18.65); 3: 45.33(18.33); 4:42.33(18.68)
and at one year: 1:43.29(18.08); 2: 42.33(20.86); 3: 42.65(13.67);
4:43.97(19.43). There was no difference between groups
(p¼0.53).Baseline LEQUESNE: 1:12.16(6.29); 2: 13.46(9.57); 3:
11.81(4.08);4:11.89(4.40) andat oneyear1:11.74(4.05);2:11.41(4.63);3:
11.68(3.62); 4: 11.86(4.30) also showed no difference (p¼0.53). Patientes
from group 4 exercised less average 1.34(2.11) times a week than the
others: 1: 2.96 (2.52) p¼0.00; 2: 2.75(2.58); p¼0.01; 3: 2.76(2.95);
p¼(0.015). BMI was measured at baseline and after a year. There were
signiﬁcant defference between groups: (1 and 4) average¼-7.19; CI95%¼
[-9.94; -4.44]; p¼0.00; (2 and 4) average¼ -4.60; CI95%¼ [-7.35; -1.849];
p¼0.000; (3 and 4) average ¼ -3.55; CI95%¼ [-6.27; -0.83]; p¼0.00.
Conclusions: The educational program (handouts, video, and work-
shops) diminished BMI and increased physical activity of the subjects.
Participating in theworkshops did not improve functional measures but
diminished pain more than just receiving handouts.279
PREOPERATIVE RESISTANCE TRAINING INCREASES MUSCLE
FUNCTION IN PATIENTS DIAGNOSED WITH HIP OSTEOARTHRITIS
SCHEDULED FOR TOTAL HIP ARTHROPLASTY – A RANDOMIZED
EXPLORATIVE TRIAL
A. Hermann y,z, A. Holsgaard-Larsen y, S. Mejdahl z, B. Zerahn x,
S. Overgaard y. yOrthopedic Res. Unit, Dept. of Orthopedics and
Traumatology, Odense Univ. Hosp., Odense, Denmark; zDept. of
Ortopedic Surgery, Herlev Univ. Hosp., Copenhagen, Denmark; xDept. of
Clinical Physiology and Nuclear Med., Herlev Univ. Hosp., Copenhagen,
Denmark
Purpose: Osteoarthritis (OA) of the hip is associated with loss of muscle
function. Resistance training (RT) increases muscle strength and func-
tion in healthy elderly and as postoperative intervention after total hip
arthroplasty (THA) in patients with hip OA. The purpose of the study
was to investigate effects of preoperative progressive (RT) on muscle
power and muscle strength in patients with hip osteoarthritis (OA)
scheduled for THA.
Methods: Eighty patients (50-88 years of age, BMI 27.94.6, 70%
female) diagnosed with hip OA and scheduled for THA were random-
ized into two groups:The intervention group (IG) received supervised
preoperative progressive RT twice a week for a period of 10 weeks. Four
exercises focusing on hip and thigh muscles were performed in 3 series
each with an intensity corresponding to 80% of 1 repetition maximum.
The control group (CG) received ‘care as usual’, deﬁned as surgery
according to the regular waiting list and preoperative information
which included a voluntary home based training program without
any RT.
Leg extension muscle power (Nottingham Powerrig, Nottingham, UK)
and maximum isometric force by isolated hip and knee extension
(custom made dynamometer, National Instruments, Texas, USA), was
measured at baseline (time of inclusion) (T0) and following interven-
tion (1-3 days prior to surgery) (T1).
